Routine compliance certificate on dematerialisation for Sep 2026 quarter

Compliance View source PDF Explain this filing

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹1075.70

prior close

₹1076.10

announcement price

In-mkt

timing

Nifty Microcap 250market-0.2%-0.2% vs market

Pharmaceuticals peers, median of 170sector-0.3%-0.1% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.1

15m

-0.2

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.2-0.2-0.3-0.1

Next day

-4.4-3.0-1.4-2.7-1.7

-4.6-2.7-1.9-2.7-2.0

-5.7-1.9-3.8-2.6-3.1

-9.6-1.7-7.8-3.0-6.6

-10.6-1.0-9.6-2.9-7.7

-12.6-2.0-10.6-3.4-9.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shilpa Medicare has submitted a compliance certificate under SEBI Depositories Regulations 74(5) for the quarter ended 30 September 2026. The certificate, issued by registrar Kfin Technologies, confirms that details of shares dematerialised and rematerialised during the quarter have been furnished to BSE and NSE. This is a standard regulatory filing and does not involve any corporate action.

Likely market impact

No material impact. This is a routine procedural filing required by SEBI every quarter.